Q3 2019 Eloxx Pharmaceuticals Inc Earnings Call Transcript
Good afternoon, everyone, and welcome to Eloxx Pharmaceutical's Third Quarter 2019 Earnings Webcast and Conference call. Today's call is being recorded. At this time, I would like to turn the call over to Barbara Ryan, Eloxx's Investor Relations Officer. Please begin.
Thank you, operator. Welcome, and thank you for joining us this afternoon for a review of Eloxx Pharmaceuticals Third Quarter 2019 Financial Results and Business Updates. Joining me this afternoon are Robert Ward, Chairman and Chief Executive Officer of Eloxx Pharmaceuticals; Dr. Greg Williams, our Chief Operating Officer; Dr. Tom Haverty, our Chief Medical Officer; and Greg Weaver, our Chief Financial Officer.
Before we begin, I'd like to remind you that any statements made during this call that are not historical are considered to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these statements as a result of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
